Oct 26, 2021

Featuring an interview with Dr Michael Mauro, including the following topics:

• Management of chronic myeloid leukemia (CML) (0:00)
• Case: A woman in her early 40s who received imatinib for 20 years for chronic-phase (CP) CML (37:45)
• Case: A man in his mid-60s with CP CML and cardiovascular risk factors (39:01)
• Case: A man in his early 50s with intermediate-risk CP CML 5 years undetectable on asciminib (40:43)

CME information and select publications